Post-TBI Irritability and Aggression: Building Evidence-Based Approaches to Management

Post-TBI Irritability and Aggression: Building Evidence-Based Approaches to Management

Overview

The purpose of the study is to see if buspirone is effective in treating irritability and aggression in people who have had a traumatic brain injury.

Description

The purpose of the study is to see if buspirone is effective in treating irritability and aggression in people who have had a traumatic brain injury.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions: Traumatic Brain Injury,1210009885
  • Age: Between 18 Years - 70 Years
  • Gender: Male or Female

Inclusion Criteria
Closed head injury at least 6 months prior to enrollment
Irritability/aggression
Observer with whom subject interacts sufficiently to observe occurences of irritability
Exclusion Criteria
Ingestion of buspirone during the month prior to enrollment
History of schizophrenia or psychosis  
Uncontrolled seizure disorder

Additional Information:
Participants will be paid for their participation.

Updated on 20 Nov 2022 . Study ID: TX3009

Connect with a study center near you

What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center